全文获取类型
收费全文 | 7313篇 |
免费 | 534篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 223篇 |
妇产科学 | 163篇 |
基础医学 | 1077篇 |
口腔科学 | 114篇 |
临床医学 | 812篇 |
内科学 | 1395篇 |
皮肤病学 | 168篇 |
神经病学 | 784篇 |
特种医学 | 224篇 |
外科学 | 760篇 |
综合类 | 57篇 |
一般理论 | 11篇 |
预防医学 | 780篇 |
眼科学 | 120篇 |
药学 | 452篇 |
中国医学 | 9篇 |
肿瘤学 | 658篇 |
出版年
2024年 | 11篇 |
2023年 | 102篇 |
2022年 | 182篇 |
2021年 | 308篇 |
2020年 | 214篇 |
2019年 | 280篇 |
2018年 | 275篇 |
2017年 | 229篇 |
2016年 | 253篇 |
2015年 | 241篇 |
2014年 | 326篇 |
2013年 | 416篇 |
2012年 | 624篇 |
2011年 | 589篇 |
2010年 | 296篇 |
2009年 | 308篇 |
2008年 | 460篇 |
2007年 | 449篇 |
2006年 | 394篇 |
2005年 | 378篇 |
2004年 | 323篇 |
2003年 | 280篇 |
2002年 | 245篇 |
2001年 | 63篇 |
2000年 | 48篇 |
1999年 | 50篇 |
1998年 | 42篇 |
1997年 | 27篇 |
1996年 | 24篇 |
1995年 | 21篇 |
1994年 | 34篇 |
1993年 | 29篇 |
1992年 | 27篇 |
1991年 | 30篇 |
1990年 | 27篇 |
1989年 | 10篇 |
1988年 | 24篇 |
1987年 | 23篇 |
1986年 | 23篇 |
1985年 | 18篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1982年 | 15篇 |
1981年 | 15篇 |
1980年 | 14篇 |
1979年 | 7篇 |
1977年 | 6篇 |
1974年 | 7篇 |
1969年 | 7篇 |
1967年 | 6篇 |
排序方式: 共有7866条查询结果,搜索用时 15 毫秒
1.
2.
3.
L Lehtola H Lehv?slaiho P Koskinen K Alitalo 《Acta oncologica (Stockholm, Sweden)》1992,31(2):147-150
As the factor binding to the neu protein has been unknown, it has not been possible to confirm experimentally the proposed growth-factor receptor like functions of the neu protein. To approach this problem we constructed a recombinant receptor which enabled ligand regulation of the neu tyrosine kinase. The hybrid receptor consisted of the extracellular ligand binding, transmembrane and protein kinase C-substrate domains joined to the intracellular tyrosine kinase and carboxyl-terminal domains of the neu protein. Several properties of NIH3T3 cells carrying this construct were tested. We obtained the first experimental evidence that the neu proto-oncogene has mitogenic and transforming activities only in the presence of a ligand stimulating its tyrosine kinase activity. Various cellular and molecular biological parameters indicated that the chimeric receptor behaved very similarly to the EGFR. Also, this chimeric receptor has allowed us to compare the constitutive oncogenic and the ligand-activated non-oncogenic activities of the neu tyrosine kinase. In the future we plan to focus on characterization of possible differences between EGFR and neu signalling in more differentiated cellular backgrounds. 相似文献
4.
5.
Seena Fazel Johanna Philipson Lisa Gardiner Rowena Merritt Martin Grann 《Journal of neurology》2009,256(10):1591-1602
The objectives of this study were to systematically review and meta-analyze the research literature on the association of common neurological disorders and violence. Keywords relating to neurological disorders and violence were searched between 1966 and August 2008. Case–control and cohort studies were selected. Odds ratios of violence risk in particular disorders compared with controls were combined using fixed-effects meta-analysis with the data presented in forest plots. Sensitivity analyses were conducted to identify possible differences in risk estimates across surveys. Information on risk factors for violence was extracted if replicated in more than one study. Nine studies were identified that compared the risk of violence in epilepsy or traumatic brain injury compared with unaffected controls. For the epilepsy studies, the overall pooled odds ratio for violent outcomes was 0.67 [95% confidence interval (CI) 0.46–0.96]. For traumatic brain injury, the odds ratio was 1.66 (95% CI 1.12–2.31). An additional 11 case–control studies investigated factors associated with violence in epilepsy and traumatic brain injury. It was not possible to meta-analyze these data. Comorbid psychopathology was associated with violence. Data on other neurological conditions was limited and unreplicated. In conclusion, although the evidence was limited and methodological quality varied, epilepsy and traumatic brain injury appeared to differ in their risk of violence compared with control populations. Longitudinal studies are required to replicate this review’s provisional findings that epilepsy is inversely associated with violence and that brain injury modestly increases the risk, and further research is needed to provide information on a broader range of risk factors. 相似文献
6.
7.
Marlies Noordzij Johanna C Korevaar Elisabeth W Boeschoten Friedo W Dekker Willem J Bos Raymond T Krediet 《Nephrology, dialysis, transplantation》2006,21(9):2676-2677
Sir, With great interest we read the editorial review of Jean etal. [1] on the relationship between hyperphosphataemia and mortalityin end-stage renal disease patients. The authors summarize resultsfrom the large USRDS and DOPPS studies in which associationsof hyperphosphataemia and increased mortality risks were 相似文献
8.
Johanna Albert Leif Kindlund Barbro Nilvér Waldemar Gożdzik 《Central European Journal of Medicine》2006,1(2):162-171
Abstract: Background: The laryngeal mask airway (LMA) can be used in general anaesthesia without neuromuscular block. The
laryngeal tube (LT) is a new airway device with similar airway features as LMA. LT is provided with a distal cuff to prevent
regurgitation. In this study we compared the LMA and LT concerning patient and user aspects.
Methods: Sixty patients with ASA (American Society of Anestesiologists) score 1–2 scheduled for minor surgery were randomized
to be ventilated either through LMA or LT. After insertion, the number of insertion attempts, and “positioning” and “airway-assessment”
was evaluated. The patients reported on “sore throat” after 30 and 60 minutes and the day after anaesthesia.
Results: Gender and mean age were equal in both groups. The first insertion attempt was successful in 25 of 28 patients randomised
to LMA and in 23 of 27 patients randomised to LT. LMA was evaluated to be easier in “positioning” whereas no difference in
“sore throat” was reported.
Conclusion: We found no difference between the LMA and the LT in terms user and patient friendliness and safety. 相似文献
9.
Localized pleural plaques and lung cancer. 总被引:1,自引:0,他引:1
T Partanen M Nurminen A Zitting H Koskinen M Wiikeri K Ahlman 《American journal of industrial medicine》1992,22(2):185-192
In a mass chest radiography survey conducted in 1971 for 7,986 residents of three Finnish communities, 604 subjects (7.6%) with pleural plaques but not other asbestos-related radiographic signs were identified. The same number of referents, each individually matched to each plaque carrier on sex, birth year, and community, was selected from among persons in the same source population with no pleural plaques. The two groups were followed for investigation of incidence of lung cancer during 1972-1989. Twenty-eight of those with plaques and 25 referents contracted lung cancer (crude conditional RR = 1.1; CL95 = 0.7, 1.9). The application of the proportional hazards model, with adjustment for sex, age, and residence, resulted in a hazard ratio of 1.1 (CL = 0.6, 1.8). The risk ratio estimate may be biased; hence, the result is inconclusive in regard to the predictive assessment of lung cancer risk among carriers of pleural plaques. 相似文献
10.
Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size 总被引:1,自引:0,他引:1
The present study describes the effect on plasma prolactin values and tumour size of bromocriptine withdrawal in 12 patients who had been treated for macroprolactinomas for a period of 3.5-7 (mean 4.9) years. Pretreatment plasma prolactin values ranged from 12,000 to 210,000 (mean: 66,000) mU/l. Immediately before bromocriptine withdrawal plasma prolactin values were in the normal range (less than 350 mU/l for men; less than 450 mU/l for women). Bromocriptine treatment was associated with tumour reduction in all cases. The following observations were made upon withdrawal of bromocriptine: (1) In 11 patients hyperprolactinaemia redeveloped although plasma prolactin levels remained below 600 mU/l in two of these patients during a follow-up period of 1 year. In the other nine patients bromocriptine treatment was reinstituted after 4-12 weeks. (2) Hyperprolactinaemia was associated with tumour reexpansion in one case and increased density of the tumour in two cases. (3) In one patient plasma prolactin remained undetectable during a follow-up period of 1 year and no tumour re-expansion was found. It is concluded that tumour regrowth is uncommon and of small extent after cessation of long-term bromocriptine treatment for macroprolactinomas. 相似文献